In this study, an acquisition protocol for glucoCESL MRI examinations in the human brain is presented, that was optimized for suppression of motion-induced artifacts. This was achieved by using a combination of (i) a 3D imaging readout, which enabled co-registration of the acquired images over the course of time, and (ii) a ΔR1ρ contrast based on quantitative R1ρ maps instead of R1ρ-weighted images. The presented acquisition protocol improves the applicability of glucose-weighted MRI for examinations in humans where motion is present. Feasibility was verified by examination in a first patient with glioblastoma.
This abstract and the presentation materials are available to members only; a login is required.